Forest Laboratories CEO Howard Solomon will no longer be barred from doing business with federal healthcare programs, according to a Bloomberg report.
The U.S. Department of Health and Human Services notified the New York-based drugmaker that it had given up efforts to ban Mr. Solomon from Medicare and Medicaid business. A judge unsealed court filings, which revealed regulators had considered starting an exclusion effort against eight of Forest’s executives related to the illegal sales of one particular drug.
Government officials refused to discuss the “deliberation of potential exclusion of specific persons or companies,” according to the report.
Read the Bloomberg report on Forest Laboratories CEO Howard Solomon.
Related Articles on Executives Banned from Medicare:
CEO of Medical Imaging Company Banned From Medicare Business for 8 Years
When the Government Targets the CEO: Forest Laboratories Event Signals Trend in White-Collar Prosecution
Forest Laboratories CEO Howard Solomon May Face Ban From Federal Health Programs
